116 related articles for article (PubMed ID: 23965952)
1. Somatic mutation of KIT is rare in small cell lung cancer patients from Northeast China.
Xuan H; Jingshu G; Fang Y; Na L; Xiaolin S; Zhaoyang Y; Meng W; Gongyan C
Histol Histopathol; 2014 Feb; 29(2):273-8. PubMed ID: 23965952
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
[TBL] [Abstract][Full Text] [Related]
3. Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients.
Bordi P; Tiseo M; Barbieri F; Bavieri M; Sartori G; Marchetti A; Buttitta F; Bortesi B; Ambrosini-Spaltro A; Gnetti L; Silini EM; Ardizzoni A; Rossi G
Lung Cancer; 2014 Dec; 86(3):324-8. PubMed ID: 25453846
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
[TBL] [Abstract][Full Text] [Related]
5. Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens.
Burger H; den Bakker MA; Stoter G; Verweij J; Nooter K
Eur J Cancer; 2003 Apr; 39(6):793-9. PubMed ID: 12651205
[TBL] [Abstract][Full Text] [Related]
6. PIK3CA Mutations in Resected Small Cell Lung Cancer.
Han N; Cheng QY; Chen B; Cai JF; Wang XJ; Lou CJ; Qin J; Ye WW; Lei L; Lu HY
Adv Clin Exp Med; 2016; 25(3):397-402. PubMed ID: 27629725
[TBL] [Abstract][Full Text] [Related]
7. KRAS Exon 3 and PTEN Exon 7 Mutations in Small-cell Lung Cancer.
Lei L; Jiang ZM; Li CH; Lu HY
Curr Med Sci; 2019 Jun; 39(3):379-384. PubMed ID: 31209806
[TBL] [Abstract][Full Text] [Related]
8. An immunohistochemical and molecular genetic analysis of KIT and PDGFRA in small cell lung carcinoma in Japanese.
Terada T
Int J Clin Exp Pathol; 2012; 5(4):331-8. PubMed ID: 22670177
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutations in small cell lung cancer.
Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y
Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487
[TBL] [Abstract][Full Text] [Related]
10. CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17.
Mojica WD; Saxena R; Starostik P; Cheney RT
Histopathology; 2005 Nov; 47(5):517-22. PubMed ID: 16242000
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
12. RET mutation and expression in small-cell lung cancer.
Dabir S; Babakoohi S; Kluge A; Morrow JJ; Kresak A; Yang M; MacPherson D; Wildey G; Dowlati A
J Thorac Oncol; 2014 Sep; 9(9):1316-23. PubMed ID: 25122427
[TBL] [Abstract][Full Text] [Related]
13. Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer.
Suda K; Murakami I; Sakai K; Mizuuchi H; Shimizu S; Sato K; Tomizawa K; Tomida S; Yatabe Y; Nishio K; Mitsudomi T
Sci Rep; 2015 Sep; 5():14447. PubMed ID: 26400668
[TBL] [Abstract][Full Text] [Related]
14. Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications.
Micke P; Basrai M; Faldum A; Bittinger F; Rönnstrand L; Blaukat A; Beeh KM; Oesch F; Fischer B; Buhl R; Hengstler JG
Clin Cancer Res; 2003 Jan; 9(1):188-94. PubMed ID: 12538468
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of KIT expression in small cell lung cancer.
López-Martin A; Ballestín C; Garcia-Carbonero R; Castaño A; Lopez-Ríos F; López-Encuentra A; Sánchez-Cespedes M; Castellano D; Bartolomé A; Cortés-Funes H; Paz-Ares L
Lung Cancer; 2007 Jun; 56(3):405-13. PubMed ID: 17420067
[TBL] [Abstract][Full Text] [Related]
16. Detection of c-kit mutational status in small-cell lung cancer in a Chinese cohort.
Cheng Y; Li H; Ma L; Zhang S; Yan S; Zhu J; Wang S; Zhang R; Niu K; Liu Y
Thorac Cancer; 2014 May; 5(3):225-31. PubMed ID: 26767005
[TBL] [Abstract][Full Text] [Related]
17. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis.
Naeem M; Dahiya M; Clark JI; Creech SD; Alkan S
Hum Pathol; 2002 Dec; 33(12):1182-7. PubMed ID: 12514786
[TBL] [Abstract][Full Text] [Related]
18. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.
Tamborini E; Bonadiman L; Negri T; Greco A; Staurengo S; Bidoli P; Pastorino U; Pierotti MA; Pilotti S
Clin Cancer Res; 2004 Dec; 10(24):8214-9. PubMed ID: 15623596
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the inwardly rectifying potassium channel Kir2.1 (KCNJ2) modulates multidrug resistance of small-cell lung cancer under the regulation of miR-7 and the Ras/MAPK pathway.
Liu H; Huang J; Peng J; Wu X; Zhang Y; Zhu W; Guo L
Mol Cancer; 2015 Mar; 14():59. PubMed ID: 25880778
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor mutations in small cell lung cancer: a brief report.
Shiao TH; Chang YL; Yu CJ; Chang YC; Hsu YC; Chang SH; Shih JY; Yang PC
J Thorac Oncol; 2011 Jan; 6(1):195-8. PubMed ID: 21178714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
